Literature DB >> 23224446

The psychiatric presentation of mitochondrial disorders in adults.

Rebecca E Anglin1, Mark A Tarnopolsky, Michael F Mazurek, Patricia I Rosebush.   

Abstract

Although comorbid psychiatric illness is increasingly being recognized in patients with mitochondrial disorders, there has been relatively little attention to psychiatric symptomatology as the primary clinical presentation. The authors report detailed clinical, biochemical, neuroradiological, and genetic findings in a series of 12 patients with mitochondrial disorders in whom psychiatric symptoms were a prominent aspect of the clinical presentation. The psychiatric presentations included depression, anorexia nervosa, bipolar disorder, and obsessive-compulsive disorder. A review of the literature, in conjunction with the present series, indicates that psychiatric symptoms can be the presenting feature of mitochondrial disorders and highlights the importance of considering this diagnosis.

Entities:  

Mesh:

Year:  2012        PMID: 23224446     DOI: 10.1176/appi.neuropsych.11110345

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  15 in total

1.  Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior.

Authors:  Avanti Gokhale; Cortnie Hartwig; Amanda A H Freeman; Julia L Bassell; Stephanie A Zlatic; Christie Sapp Savas; Trishna Vadlamudi; Farida Abudulai; Tyler T Pham; Amanda Crocker; Erica Werner; Zhexing Wen; Gabriela M Repetto; Joseph A Gogos; Steven M Claypool; Jennifer K Forsyth; Carrie E Bearden; Jill Glausier; David A Lewis; Nicholas T Seyfried; Jennifer Q Kwong; Victor Faundez
Journal:  J Neurosci       Date:  2019-03-04       Impact factor: 6.167

2.  A 54-year-old man with hallucinations and hearing loss.

Authors:  Claude Steriade; Steven L Shumak; Anthony Feinstein
Journal:  CMAJ       Date:  2014-06-30       Impact factor: 8.262

3.  Mitochondrial Dysfunction in Psychiatric Illness.

Authors:  Rebecca Anglin
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

4.  Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

Authors:  Jasna David; Julie Omolola Okiro; Kevin Murphy; Marwa Elamin
Journal:  BMJ Case Rep       Date:  2017-02-27

5.  Metabolite measurements in the caudate nucleus, anterior cingulate cortex and hippocampus among patients with mitochondrial disorders: a case-control study using proton magnetic resonance spectroscopy.

Authors:  Rebecca E Anglin; Patricia I Rosebush; Michael D Noseworthy; Mark Tarnopolsky; Alexander M Weber; Noam Soreni; Michael F Mazurek
Journal:  CMAJ Open       Date:  2013-04-26

Review 6.  Mitophagy in depression: Pathophysiology and treatment targets.

Authors:  Ashutosh Tripathi; Giselli Scaini; Tatiana Barichello; João Quevedo; Anilkumar Pillai
Journal:  Mitochondrion       Date:  2021-08-31       Impact factor: 4.160

7.  Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders.

Authors:  R E Anglin; P I Rosebush; M D Noseworthy; M Tarnopolsky; M F Mazurek
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

8.  Mitochondrial mutations in subjects with psychiatric disorders.

Authors:  Adolfo Sequeira; Brandi Rollins; Christophe Magnan; Mannis van Oven; Pierre Baldi; Richard M Myers; Jack D Barchas; Alan F Schatzberg; Stanley J Watson; Huda Akil; William E Bunney; Marquis P Vawter
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease.

Authors:  Nichola Z Lax; John Grady; Alex Laude; Felix Chan; Philippa D Hepplewhite; Grainne Gorman; Roger G Whittaker; Yi Ng; Mark O Cunningham; Doug M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-30       Impact factor: 8.090

Review 10.  Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects.

Authors:  Lilach Toker; Galila Agam
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.